Patent · US Active

Combination therapy for the treatment of autoimmune diseases

US10413605B2 · kind B2 · utility

2Cited by

0References

10Claims

0Family size

Assignee

Fraunhofer-Gesellschaft zur förderung der angewandten Forschung e.V. · DE

Inventors

Urs Christen · Pieterlen, CH
STANLEY LASCH · Darmstadt, DE
Michael Parnham · Bad Soden am Taunus, DE

Key dates

Filing date	Apr 8, 2014
Grant date	Sep 17, 2019
Priority date	—
Expiry date	Apr 8, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention pertains to compounds and their combination for use in the prevention or therapy of a subject suffering from an autoimmune disease such as diabetes type 1. Provided are antagonists of T-cells that are used in combination with antagonists of the cytokine CXCL10, sequentially or concomitantly, in a subject suffering from an autoimmune disease, in particular diabetes type 1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.